Losartan Potassium Tablet, Film Coated
Product Images NDC 63187-357

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 63187-357). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

63187-357-30 (Losartan25mg30s)

63187-357-30 (Losartan25mg30s)
This is a description of a medication called Losartan Potassium 25mg, which is packaged by Profcent RxLe. The medication is in tablet form and each film coated tablet contains 25mg Losartan Potassium USP. The tablets are white to off-white and oval shaped with ' on one side and '5' on the other side. The product is identified by Product ID PL035730 and Lot #00000 ExpOD0000, and is stored at 20°-25°C (68°-77°F). The medication is manufactured by Hetero™ Hetero Labs Limited and is for RX only.*
FDA Label Image

Losartanaddress1 (Losartanaddress1)

FDA Label Image

Losartanaddress2 (Losartanaddress2)

FDA Label Image

Losartanfigure1 (Losartanfigure1)

FDA Label Image

Losartanfigure2 (Losartanfigure2)

Losartanfigure2 (Losartanfigure2)
This text seems to present data from a study with results showing a 26% decrease in adjusted risk reduction with a p-value of 0.001. The study was likely conducted over a period of 66 months, with data collected at various intervals (6, 12, 18, 24, 30, 36, 42, 48, 54, and 60 months). The percentage of patients with a first-line or fatal stroke may have also been recorded.*
FDA Label Image

Losartanfigure3 (Losartanfigure3)

FDA Label Image

Losartanfigure4 (Losartanfigure4)

Losartanfigure4 (Losartanfigure4)
The text "Risk Reduction = 0022 18.1% Months" suggests that there is a certain risk reduction value of 0.022 and a percentage of reduction of 18.1% for a specific duration of time, which is not specified. The phrase "% Patents with Event" seems to be a header for a table or a graph, but no further information is available.*
FDA Label Image

Losartanstructure (Losartanstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.